Literature DB >> 573283

The interrelationships among prolactin, 1,25-dihydroxyvitamin D, and parathyroid hormone in humans.

N D Adams, T L Garthwaite, R W Gray, T C Hagen, J Lemann.   

Abstract

Serum PRL, parathyroid hormone (PTH), and plasma 1,25-dihydroxyvitamin D [1,25(OH)2D]concentrations were measured in 6 women and 2 men with hyperprolactinemia, 6 normal men and 7 normal women, 4 men and 4 women with primary hyperparathyroidism, and 16 men and 4 women with Ca nephrolithiasis. Plasma 1,25(OH)2D and serum parathyroid hormone (PTH) concentrations were normal in the women and men with hyperprolactinemia. In patients with primary hyperparathyroidism and elevated serum PTH, plasma 1,25(OH)2D concentrations were elevated but serum PRL levels were normal. Likewise, serum PRL levels were normal in patients with Ca nephrolithiasis who had significantly elevated plasma, 1,25(OH)2D concentrations and normal serum PTH concentrations. Thus, hyperprolactinemia due to pituitary adenoma or idiopathic hypersecretion is not accompanied but elevated plasma concentrations of 1,25(OH)2D.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 573283     DOI: 10.1210/jcem-49-4-628

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  9 in total

Review 1.  Vitamin D and the kidney.

Authors:  Rajiv Kumar; Peter J Tebben; James R Thompson
Journal:  Arch Biochem Biophys       Date:  2012-03-15       Impact factor: 4.013

Review 2.  Vitamin D-Mediated Hypercalcemia: Mechanisms, Diagnosis, and Treatment.

Authors:  Peter J Tebben; Ravinder J Singh; Rajiv Kumar
Journal:  Endocr Rev       Date:  2016-09-02       Impact factor: 19.871

3.  Influence of pregnancy on immunoreactive parathyroid hormone levels.

Authors:  M E Gillette; K L Insogna; A M Lewis; D T Baran
Journal:  Calcif Tissue Int       Date:  1982-01       Impact factor: 4.333

4.  Control of plasma 1,25-(OH)2-vitamin D concentrations by calcium and phosphorus in the rat: effects of hypophysectomy.

Authors:  R W Gray
Journal:  Calcif Tissue Int       Date:  1981       Impact factor: 4.333

Review 5.  The effects of hyperprolactinemia on bone and fat.

Authors:  Amal Shibli-Rahhal; Janet Schlechte
Journal:  Pituitary       Date:  2009       Impact factor: 4.107

6.  Prolactin and calcium metabolism: influence of hyperprolactinemia on immunoreactive parathyroid hormone levels in man and in the rat.

Authors:  C E Fiore; R D'Agata; G Clementi; L S Malatino
Journal:  J Endocrinol Invest       Date:  1984-12       Impact factor: 4.256

7.  Increased forearm bone mineral content after bromocriptine treatment in hyperprolactinemia.

Authors:  M P Caraceni; E Corghi; S Ortolani; S Casazza; A D'Alberton; T Motta
Journal:  Calcif Tissue Int       Date:  1985-12       Impact factor: 4.333

8.  Control of vitamin D metabolism in preterm infants: feto-maternal relationships.

Authors:  E E Delvin; F H Glorieux; B L Salle; L David; J P Varenne
Journal:  Arch Dis Child       Date:  1982-10       Impact factor: 3.791

9.  Prolactin receptor in primary hyperparathyroidism--expression, functionality and clinical correlations.

Authors:  Felix Haglund; Ming Lu; Vladana Vukojević; Inga-Lena Nilsson; Adam Andreasson; Mensur Džabić; Robert Bränström; Anders Höög; C Christofer Juhlin; Catharina Larsson
Journal:  PLoS One       Date:  2012-05-11       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.